Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationGranulocyte Colony-Stimulating FactorTransplantation, HomologousTransplantation ConditioningLeukapheresisAntigens, CD34MelphalanBlood Component RemovalHematologic NeoplasmsCombined Modality TherapyBone Marrow TransplantationCyclophosphamideStem Cell TransplantationHematopoietic Stem CellsMultiple MyelomaGraft vs Host DiseaseAntineoplastic Combined Chemotherapy ProtocolsBusulfanMyeloablative AgonistsGraft SurvivalTreatment OutcomeLymphoma, Non-HodgkinStem CellsBone MarrowEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceHematopoiesisCarmustineIfosfamideBone Marrow CellsCord Blood Stem Cell TransplantationCytophagocytosisVincristineSalvage TherapyCytarabineTransplantation ChimeraTissue DonorsAmyloidosisDisease-Free SurvivalHodgkin DiseaseWhole-Body IrradiationBlood Cell CountRetrospective StudiesNeoplasmsSurvival RateBlood CellsTime FactorsPlatelet CountHistocompatibilityInfectionRecombinant ProteinsSurvival AnalysisDoxorubicinBone Marrow PurgingPOEMS SyndromeHistocompatibility TestingLeukemiaLeukemia, Myeloid, AcuteImmunosuppressive AgentsLymphoma, T-CellTransplantation, IsogeneicVidarabineCarboplatinLeukocytes, MononuclearPrednisoneLymphomaBone Marrow DiseasesDexamethasoneImmunophenotypingFollow-Up StudiesAnemia, AplasticCytomegalovirus InfectionsAntineoplastic AgentsFeasibility StudiesProspective StudiesFlow CytometryT-LymphocytesGraft vs Leukemia EffectMyelodysplastic SyndromesFatal OutcomeBlood DonorsCell SeparationLeukocyte CountLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionHematologic DiseasesCells, CulturedAntigens, CDColony-Forming Units AssayHistiocytosis, Non-Langerhans-CellImmunomagnetic SeparationCell DifferentiationPrecursor Cell Lymphoblastic Leukemia-LymphomaEmbryonic Stem Cells